Related Experiment Video
Updated: Jul 7, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Chronic Nonbacterial Osteomyelitis in Inflammatory Bowel Disease
Ariadni Tzaneti1, Elli Athanasopoulou1, Smaragdi Fessatou2
1Department of Pediatrics, Attikon General Hospital, National and Kapodistrian University of Athens, 124 62 Athens, Greece.
Chronic nonbacterial osteomyelitis (CNO) and inflammatory bowel disease (IBD) share genetic and immune pathways. Early recognition of their connection in children can improve treatment outcomes for these autoinflammatory conditions.
Area of Science:
- Pediatric Rheumatology
- Gastroenterology
- Immunology
Background:
- Chronic nonbacterial osteomyelitis (CNO), or chronic recurrent multifocal osteomyelitis (CRMO), is a rare pediatric autoinflammatory bone disorder.
- Inflammatory bowel disease (IBD) encompasses chronic inflammatory conditions of the gastrointestinal tract.
- Both CNO and IBD present with systemic manifestations and share extraintestinal symptoms.
Purpose of the Study:
- To analyze the relationship between CNO and IBD.
- To investigate shared pathophysiological mechanisms and clinical management strategies.
- To highlight the importance of recognizing co-occurrence in pediatric patients.
Main Methods:
- Comprehensive literature review of 24 case reports involving 40 patients.
- Analysis of demographic data, diagnosis patterns, and time intervals between disease presentations.
- Review of treatment modalities and underlying pathophysiological factors.
Main Results:
- Median age of diagnosis for CNO/IBD was 12 years, with a near-equal gender distribution.
- CNO was often the initial diagnosis; Crohn's disease was more common than ulcerative colitis.
- Shared treatments (NSAIDs, steroids, biologics) and genetic factors (IL-10 polymorphisms) suggest common pathways.
Conclusions:
- CNO and IBD share immunological and genetic links, including cytokine dysregulation and innate immune system involvement.
- The microbiome may play a role in CNO pathophysiology, similar to its role in IBD.
- Increased clinical awareness of CNO-IBD co-occurrence is crucial for improved pediatric patient management and outcomes.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

